Cheryl Ann Thaxton, NP
NPI 1013919539ActiveIndividual· Nurse Practitioner· Dallas, TX
Nurse Practitioner (NP) in Dallas, Texas, licensed in TX, with an NPI issued in August 2005. Otsuka Pharmaceutical Development & Commercialization, Inc. was the largest of 3 companies reporting payments in 2025, $366.78 in all, mostly food and beverage.
Overview
| NPI | 1013919539 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | NP |
| Sole proprietor | No |
| NPI issued | Aug 15, 2005 |
| Last updated in NPPES | Jul 21, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Nurse Practitioner Primary | 363L00000X | AP126335 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$366.78 · 3 payments from 3 companies
- 2024$16.61 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $124.98 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.12 | 1 |
| Sanofi-Aventis U.S. LLC | $118.68 | 1 |
What the 2025 payments were for
- Food and Beverage$366.78 · 3 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other nurse practitioners in Dallas
- 1003555178
- 1043383201
- 1043442254
- 1043685654
- 1063768737
- 1063952851
- 1073051520
- 1073559886
- 1114504248
- 1124412770
- 1124462247
- 1124479696
All 486 nurse practitioners in Dallas · All nurse practitioners in Texas